Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2.77M
-
Shares change
-
-171K
-
Total reported value, excl. options
-
$7.43M
-
Value change
-
-$464K
-
Number of buys
-
5
-
Number of sells
-
-11
-
Price
-
$2.68
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2021
26 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q3 2021.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.77M shares
of 15M outstanding shares and own 18.5% of the company stock.
Largest 10 shareholders include DIMENSIONAL FUND ADVISORS LP (697K shares), RENAISSANCE TECHNOLOGIES LLC (665K shares), VANGUARD GROUP INC (392K shares), BlackRock Inc. (333K shares), BERKSHIRE ASSET MANAGEMENT LLC/PA (176K shares), ACADIAN ASSET MANAGEMENT LLC (162K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (161K shares), GEODE CAPITAL MANAGEMENT, LLC (51.5K shares), Sterling Financial Planning, Inc. (22K shares), and NORTHERN TRUST CORP (20.2K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.